I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MPP2+ Recurrent or Progressive Glioblastoma
This phase I trial studies the side effects and best dose of chimeric antigen receptor (CAR) T cells with a chlorotoxin tumor-targeting domain in treating patients with MPP2+ glioblastoma that has come back (recurrent) or that is growing, spreading, or getting worse (progressive). Vaccines made from a gene-modified virus may …
neutrophil count
serum pregnancy test
expression by immunohistochemistry
HIV Infection
mpp2
- 0 views
- 19 Feb, 2024